Boxer Capital as of Dec. 31, 2019
Portfolio Holdings for Boxer Capital
Boxer Capital holds 51 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Mirati Therapeutics | 12.5 | $221M | 1.7M | 128.86 | |
Immunomedics | 10.1 | $179M | 8.5M | 21.16 | |
Beigene (BGNE) | 8.7 | $153M | 925k | 165.76 | |
Odonate Therapeutics Ord | 6.2 | $109M | 3.4M | 32.45 | |
Medicines Company | 4.7 | $82M | 967k | 84.94 | |
Springworks Therapeutics (SWTX) | 4.5 | $80M | 2.1M | 38.49 | |
Dbv Technologies S A (DBVT) | 3.9 | $68M | 6.4M | 10.70 | |
Allakos (ALLK) | 3.6 | $64M | 675k | 95.36 | |
Esperion Therapeutics (ESPR) | 3.3 | $58M | 975k | 59.63 | |
Seattle Genetics | 3.2 | $57M | 500k | 114.26 | |
Uniqure Nv (QURE) | 3.1 | $55M | 765k | 71.66 | |
Direxion Shs Etf Tr Daily S&p Biotec | 2.0 | $36M | 2.9M | 12.35 | |
Gossamer Bio (GOSS) | 1.9 | $34M | 2.2M | 15.63 | |
Rocket Pharmaceuticals (RCKT) | 1.9 | $33M | 1.5M | 22.76 | |
Argenx Se (ARGX) | 1.8 | $32M | 200k | 160.52 | |
Sarepta Therapeutics (SRPT) | 1.6 | $29M | 225k | 129.04 | |
Kadmon Hldgs | 1.6 | $28M | 6.2M | 4.53 | |
Atreca Inc Cl A (BCEL) | 1.5 | $27M | 1.7M | 15.47 | |
Sage Therapeutics (SAGE) | 1.4 | $25M | 350k | 72.19 | |
Apellis Pharmaceuticals (APLS) | 1.4 | $25M | 800k | 30.62 | |
Matinas Biopharma Holdings, In (MTNB) | 1.3 | $23M | 10M | 2.27 | |
Amicus Therapeutics (FOLD) | 1.3 | $23M | 2.3M | 9.74 | |
Cabaletta Bio (CABA) | 1.2 | $22M | 1.6M | 13.97 | |
BioMarin Pharmaceutical (BMRN) | 1.2 | $21M | 250k | 84.55 | |
Anaptysbio Inc Common (ANAB) | 1.2 | $21M | 1.3M | 16.25 | |
Global Blood Therapeutics In | 1.1 | $20M | 250k | 79.49 | |
Achillion Pharmaceuticals | 1.0 | $18M | 3.0M | 6.07 | |
Prevail Therapeutics Ord | 1.0 | $18M | 1.1M | 15.83 | |
Milestone Pharmaceuticals (MIST) | 1.0 | $18M | 1.1M | 16.01 | |
Arcus Biosciences Incorporated (RCUS) | 1.0 | $17M | 1.7M | 10.10 | |
Barclays Bk Plc cmn | 0.9 | $15M | 1.0M | 15.12 | |
Arvinas Ord (ARVN) | 0.8 | $15M | 366k | 41.09 | |
Bellus Health | 0.8 | $14M | 1.8M | 7.60 | |
Neoleukin Therapeutics | 0.7 | $12M | 1.0M | 12.32 | |
Kura Oncology (KURA) | 0.7 | $12M | 845k | 13.75 | |
Relmada Therapeutics (RLMD) | 0.7 | $12M | 300k | 39.00 | |
Lexicon Pharmaceuticals (LXRX) | 0.7 | $12M | 2.8M | 4.15 | |
Akero Therapeutics (AKRO) | 0.6 | $11M | 483k | 22.20 | |
Marinus Pharmaceuticals | 0.6 | $10M | 4.8M | 2.16 | |
Medicines | 0.5 | $8.5M | 100k | 84.94 | |
Selecta Biosciences (RNAC) | 0.4 | $7.8M | 3.3M | 2.38 | |
Mirum Pharmaceuticals (MIRM) | 0.4 | $7.8M | 317k | 24.52 | |
Mei Pharma | 0.4 | $7.2M | 2.9M | 2.48 | |
Ideaya Biosciences (IDYA) | 0.3 | $5.7M | 764k | 7.50 | |
Solid Biosciences | 0.3 | $4.6M | 1.0M | 4.45 | |
Cymabay Therapeutics | 0.2 | $3.9M | 2.0M | 1.96 | |
Kalvista Pharmaceuticals (KALV) | 0.2 | $3.6M | 200k | 17.81 | |
Kiniksa Pharmaceuticals (KNSA) | 0.2 | $3.2M | 291k | 11.06 | |
La Jolla Pharmaceuticl Com Par | 0.2 | $3.0M | 775k | 3.93 | |
Syndax Pharmaceuticals (SNDX) | 0.1 | $2.2M | 250k | 8.78 | |
Cellectar Biosciences | 0.1 | $2.1M | 920k | 2.25 |